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Noncentral Mitral Regurgitation
A New Niche for the MitraClip*
Jason H. Rogers, MD, Reginald I. Low, MD
Sacramento, California
MitraClip therapy (Abbott, Abbott Park, Illinois) is an
important treatment for correcting clinically signiﬁcant
mitral regurgitation (MR) in patients at increased risk for
surgery. This therapy can now be offered to many patients
with comorbidities who are at high surgical risk and would
not otherwise undergo surgery because of perceived excessive
morbidity and mortality (1). The MitraClip system was CE-
mark approved in March 2008, and over 8,000 patients have
been treated worldwide to date, mostly in Europe, and
predominantly in those at high surgical risk with functional
mitral regurgitation (FMR). During this time, the Mitra-
Clip system has remained investigational in the United
States until October 2013, when FDA approval was granted
for patients at high surgical risk with degenerative MR.
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Despite a high prevalence of FMR treatment, approxi-
mately 25% of high surgical risk patients currently being
treated worldwide have degenerative MR (DMR), and this
remains a very important target population (2,3). Unlike
aortic stenosis, which generally has a singular pathology
(calciﬁc leaﬂet stenosis), the etiologies of MR are highly
varied. Because MR can result from a multitude of pa-
thologies, identifying speciﬁc subgroups of MR that
would beneﬁt from catheter-based MR correction is
important.
In this issue of the Journal, Estévez-Loureiro et al. (4)
report the ﬁrst patient series using the MitraClip system
to treat noncentral DMR. The authors describe results from
3 highly experienced centers in Europe using the MitraClip
in patients with DMR who are at high risk for surgery as
determined by a multidisciplinary heart team. This unique
analysis consists of examining procedural and short-term
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from MR correction. Patients were excluded for primarily
anatomic reasons that would preclude MitraClip implanta-
tion, such as a ﬂail gap >20 mm, active endocarditis,
intracardiac thrombus, mitral stenosis, or other anatomy
unsuitable for transseptal puncture. The paper highlights
several important technical considerations for the treatment
of noncentral MR. It is noted that there is a complex
structure of fan-shaped subcommissural chordae, which
could increase the risk of MitraClip entanglement. In this
series, clip entanglement, deﬁned as manipulation of the
system >120 s to free the MitraClip, did not occur, which
speaks to the experience of these operators. There are also
other important technical considerations, including optimi-
zation of transseptal puncture height, and liberal use of
3-dimensional transesophageal echocardiography. The Mi-
traClip delivery system is versatile and allows placement of
the MitraClip in a wide variety of locations along the
coaptation line of the mitral leaﬂets. For medial jets, it is
often necessary to retract the guide catheter into the right
atrium, whereas for lateral jets, the system must be advanced
more deeply into the left atrium than for central pathologies
(Fig. 1). Despite these technical nuances, the authors re-
ported equivalent outcomes with both patient groups:
speciﬁcally, those patients with noncentral versus central
DMR had similar procedural success, MR reduction, New
York Heart Association functional class, adverse events, heart
failure admissions, and death.
The treatment of noncentral MR with the edge-to-edge
technique is not a new concept, and has been reported by
many in the surgical literature. Alﬁeri et al. (5) ﬁrst
described the surgical edge-to-edge repair technique as
using suture to approximate the A2–P2 segments of the
mitral valve, thereby converting a single regurgitant mitral
oriﬁce into a competent double-oriﬁce valve with decreased
regurgitation. The surgical management of noncentral or
paracommissural prolapse can be technically challenging,
and multiple repair techniques have been described,
including partial leaﬂet resection, annular plication, and
chordal transfer. In the setting of endocarditis with leaﬂet
destruction, surgeons have used autologous pericardium,
autologous tricuspid valve posterior leaﬂet, or partial mitral
homografts (6). However, numerous surgical reports have
established the simplicity and efﬁcacy of edge-to-edge
repair for noncentral MR.
Alﬁeri et al. (5) has described that the edge-to-edge
technique can be applied successfully to noncentral MR.
This paracommissural edge-to-edge repair results in a
single-oriﬁce mitral valve with a relatively smaller area
(Fig. 2). In the words of Alﬁeri et al. (5): “commissural edge-
to-edge repair with annuloplasty is probably the simplest
and most reproducible method to repair commissural
lesions.” Mathieu et al. (6) have reported on the use of
the edge-to-edge technique in 115 patients with isolated
commissural prolapse or ﬂail. The freedom from reoperation
at 5 years was 97.5%. In 108 patients with echocardiography
Figure 1 MitraClip Guide and Delivery System Positioning for Treatment of Paracommissural Mitral Regurgitation
(A to D) Treatment of medial regurgitant jets (A3/P3) may require the MitraClip guide (white arrows) to be pulled back to the interatrial septum or right atrium. (E and F) Lateral
jets require the guide to be advanced more deeply into the left atrium, with less deﬂection. Because the system gains height as it crosses the left atrium, a relatively lower
transseptal puncture site may be required. Images generated on MitraClip Virtual Procedure Software, version 2.12.5.2, Abbott Vascular Structural Heart, Abbott Park, Illinois.
A1/A2/A3 ¼ segments of the anterior mitral leaﬂet; IVC ¼ inferior vena cava; LA ¼ left atrium; P1/P2/P3 ¼ scallops of the posterior mitral leaﬂet; RA ¼ right atrium.
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2379at a mean follow-up of 2.3  1.9 years (median 2.0 years,
range 1 to 8.3 years), MR was absent in 60 patients (55.6%),
mild in 43 (39.8%), moderate in 3 (2.8%), and severe in 2
(1.9%, both reoperated on). There were no cases of mitral
stenosis (7,8).
Other reports include Gillinov et al. (9) from the Cleve-
land Clinic who reported using this technique in more
than 100 patients, with no instances of mitral stenosis,suture dehiscence, or recurrent prolapse at the site of repair.
Aubert et al. (10) reported a retrospective analysis of 128
consecutive patients who underwent surgical mitral valve
repair for commissural prolapse; 65 (50.8%) were treated with
edge-to-edge commissural closure. There were no cases of
mitral stenosis resulting from repair, and transthoracic
echocardiography at discharge showed no residual mitral
insufﬁciency in 94 cases (73.4%) and grade 1 in 34 cases
Figure 2 Surgical Edge-to-Edge Repair of Lateral Paracommissural DMR
The repair with implantation of an annuloplasty ring, and analogous MitraClip repair (lower right panel), are shown. DMR ¼ degenerative mitral regurgitation. Adapted and
reprinted with permission from Gillinov et al. (9).
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2380(26.6%). Excellent outcomes were reported, with 96.7%
survival and 96.6% freedom from mitral valve reoperation
at 5 years (10). Finally, Shimomura et al. (11) reported the
use of the edge-to-edge technique in 12 patients with
commissural prolapse due to degenerative disease with no
signiﬁcant recurrence of regurgitation at a mean follow-up
interval of 49.8 months. In all surgical series, an annulo-
plasty ring was implanted at the time of paracommissural
edge-to-edge repair.
Given the success of surgical edge-to-edge repair, the
current article is a very important clinical report, and for the
ﬁrst time, addresses outcomes in MitraClip patients with
noncentral DMR. Although the U.S. EVEREST (Endo-
vascular Valve Edge-to-Edge Repair) trials and REALISM
(Real World ExpAnded MuLtIcenter Study of the Mitra-
Clip System) continued access registry have limited therapy
to patients with predominantly central (A2/P2) MR, it is
well known that treatment in Europe and in the U.S.
Compassionate Use Pathway has included patients with
noncentral MR. Until now, we have not had any formal
reports describing this technique.
It is also notable in the current report by Estévez-Loureiro
et al. (4) that of 173 high-risk surgical patients treated at
these centers with the MitraClip from 2009 to 2012, 70
(46%) had DMRdthis is somewhat higher than expected
because the general impression is that the majority of patients
being treated outside the United States are patients with
FMR. It is also notable that approximately one-third (38%)
of patients with DMR had noncentral DMR, highlighting
the signiﬁcant prevalence of noncentral MR. These patient
characteristics and results are very important for deﬁning
the patient groups eligible for treatment, and also highlightthat of high-risk patients, a signiﬁcant number have degen-
erative and noncentral MR, and should be considered can-
didates for this therapy.
In summary, the authors have provided evidence that
MitraClip therapy may be expanded to include a new
nichedtreatment of noncentral MR. One would advise
that further reports are needed, and a more systematic
description of protocol/technique is necessary before
widespread adoption by lower volume or less experienced
MitraClip operators. Nonetheless, it appears that the
procedure can be done safely in patients with noncentral
MR, with clinical outcomes that are similar to the treatment
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